<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cellular processes</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Elimination of two ribosome subunits activates cell cycle control</title>
   	 <description>Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes and the emergence of various diseases. Now, scientists at the Bellvitge Biomedical Research Institute (IDIBELL) have found that this response is achieved independently, depending on which subunit of the ribosome (40S and 60S) is impaired, by the joint action of two proteins of the ribosome. The research results are published in the latest issue of the journal Genes and Development.</description>
     <link>http://medicalxpress.com/news/2012-05-ribosome-subunits-cell.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 22 May 2012 10:39:10 EST</pubDate>
	 <guid isPermaLink="false">news256901871</guid>
	 
</item>
<item>
     <title>Study finds cancer-fighting goodness in cholesterol</title>
   	 <description>A Simon Fraser University researcher is among four scientists who argue that cholesterol may slow or stop cancer cell growth. They describe how cholesterol-binding proteins called ORPs may control cell growth in A Detour for Yeast Oxysterol Binding Proteins, a paper published in the latest issue of the Journal of Biological Chemistry.</description>
     <link>http://medicalxpress.com/news/2012-04-cancer-fighting-goodness-cholesterol.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 Apr 2012 16:20:02 EST</pubDate>
	 <guid isPermaLink="false">news254070769</guid>
	 
</item>
<item>
     <title>Newly found protein helps cells build tissues</title>
   	 <description>As they work together to form body parts, cells in developing organisms communicate like workers at a construction site. The discovery of a new signaling molecule in flies by Brown University biologists not only helps explain how cells send many long-haul messages, but also provides new clues for researchers who study how human development goes awry, for instance in cases of cleft lip and palate.</description>
     <link>http://medicalxpress.com/news/2012-04-newly-protein-cells-tissues.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 02 Apr 2012 11:03:20 EST</pubDate>
	 <guid isPermaLink="false">news252583391</guid>
	 
</item>
<item>
     <title>Protein Aurora-A is found to be associated with survival in head and neck cancer</title>
   	 <description>Researchers at Fox Chase Cancer Center in Philadelphia have found that a protein associated with other cancers appears to also be important in head and neck cancer, and may consequently serve as a good target for new treatments. The findings will be reported at the AACR Annual Meeting 2012 on Sunday, April 1.</description>
     <link>http://medicalxpress.com/news/2012-04-protein-aurora-a-survival-neck-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 01 Apr 2012 14:40:20 EST</pubDate>
	 <guid isPermaLink="false">news252510005</guid>
	 
</item>
<item>
     <title>Researchers find important 'target' playing role in tobacco-related lung cancers</title>
   	 <description>Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce IKBKE and, in turn, IKBKE induces chemotherapy resistance.</description>
     <link>http://medicalxpress.com/news/2012-02-important-role-tobacco-related-lung-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Feb 2012 12:55:37 EST</pubDate>
	 <guid isPermaLink="false">news248014519</guid>
	 
</item>
<item>
     <title>Researchers pave the way for improving treatment for Type 2 diabetes</title>
   	 <description>In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body. This discovery has important implications for drugs currently in development to treat Type 2 diabetes, a disease which is diagnosed every 10 seconds somewhere throughout the world.</description>
     <link>http://medicalxpress.com/news/2012-02-pave-treatment-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 07 Feb 2012 10:12:52 EST</pubDate>
	 <guid isPermaLink="false">news247831963</guid>
	 
</item>
<item>
     <title>Gene linked to pancreatic cancer growth, study finds</title>
   	 <description>A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers. The finding suggests a possible target for developing new ways to treat this deadly disease.</description>
     <link>http://medicalxpress.com/news/2012-01-gene-linked-pancreatic-cancer-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 31 Jan 2012 11:08:43 EST</pubDate>
	 <guid isPermaLink="false">news247230516</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genelinkedto.jpg" width="90" height="87" />
</item>
<item>
     <title>Detailed picture of how myoV 'walks' along actin tracks</title>
   	 <description>A new study in the Journal of General Physiology uses state-of-the-art fluorescence microscopy to provide a striking 3-D picture of how class V myosins (myoV) &quot;walk&quot; along their actin track.</description>
     <link>http://medicalxpress.com/news/2012-01-picture-myov-actin-tracks.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 30 Jan 2012 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news247144773</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/detailedpict.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists uncover novel mechanism of glioblastoma development</title>
   	 <description>Most research on glioblastoma development, a complicated tumor of the brain with a poor prognosis, has focused on the gene transcription level, but scientists suggest that post-transcriptional regulation could be equally or even more important.</description>
     <link>http://medicalxpress.com/news/2012-01-scientists-uncover-mechanism-glioblastoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 Jan 2012 03:46:26 EST</pubDate>
	 <guid isPermaLink="false">news246080765</guid>
	 
</item>
<item>
     <title>Internal skin cancer prevention: Repairing UV damage in the skin</title>
   	 <description>(Medical Xpress) -- Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI) of the Novartis Research Foundation have elucidated the mechanisms underlying the repair of UV-induced damage in DNA, which frequently causes skin cancer. The protein structures additionally determined by these researchers will improve our understanding of how the body protects itself against skin cancer. These studies lay the foundations for the development of a new class of anti cancer agents. The findings were published today in Cell.</description>
     <link>http://medicalxpress.com/news/2011-11-internal-skin-cancer-uv.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 24 Nov 2011 07:55:16 EST</pubDate>
	 <guid isPermaLink="false">news241343677</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/internalskin.jpg" width="90" height="90" />
</item>
<item>
     <title>MU scientist eyeing enzymes that could help fight flu</title>
   	 <description>The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another flu season, a University of Missouri scientist is studying how two enzymes could be used to stop the virus in its tracks.</description>
     <link>http://medicalxpress.com/news/2011-11-mu-scientist-eyeing-enzymes-flu.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 17 Nov 2011 10:21:38 EST</pubDate>
	 <guid isPermaLink="false">news240747681</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/muscientiste.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists discover how to design drugs that could target particular nerve cells</title>
   	 <description>(Medical Xpress) -- The future of drug design lies in developing therapies that can target specific cellular processes without causing adverse reactions in other areas of the nervous system. Scientists at the Universities of Bristol and Li&amp;#232;ge in Belgium have discovered how to design drugs to target specific areas of the brain.</description>
     <link>http://medicalxpress.com/news/2011-11-scientists-drugs-nerve-cells.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 10 Nov 2011 07:34:09 EST</pubDate>
	 <guid isPermaLink="false">news240132839</guid>
	 
</item>
<item>
     <title>Vitamin B derivative helps diabetics with mild kidney disease</title>
   	 <description>A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The drug may benefit increasing numbers of patients as the prevalence of diabetes rises.</description>
     <link>http://medicalxpress.com/news/2011-10-vitamin-derivative-diabetics-mild-kidney.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 27 Oct 2011 17:32:17 EST</pubDate>
	 <guid isPermaLink="false">news238955512</guid>
	 
</item>
<item>
     <title>Antineoplastic agents associated with thyroid dysfunction</title>
   	 <description>Antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction in 20%-50% of cancer patients taking them, which can adversely affect patients' quality of life, according to a study published Oct. 18 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-10-antineoplastic-agents-thyroid-dysfunction.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 18 Oct 2011 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news238155456</guid>
	 
</item>
<item>
     <title>AMPK amplifies Huntington's disease</title>
   	 <description>A new study describes how hyperactivation of AMP-activated protein kinase (AMPK) promotes neurodegeneration in Huntington's disease (HD). The article appears online on July 18, 2011, in The Journal of Cell Biology.</description>
     <link>http://medicalxpress.com/news/2011-07-ampk-amplifies-huntington-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 18 Jul 2011 12:28:15 EST</pubDate>
	 <guid isPermaLink="false">news230210876</guid>
	 
</item>
<item>
     <title>ASU bioengineers will expand work to solve cardiovascular health challenges</title>
   	 <description>Biomedical research at Arizona State University will be boosted with support from the American Heart Association for the work of three bioengineers.</description>
     <link>http://medicalxpress.com/news/2011-06-asu-bioengineers-cardiovascular-health.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 28 Jun 2011 16:28:47 EST</pubDate>
	 <guid isPermaLink="false">news228497287</guid>
	 
</item>
<item>
     <title>Hope for infant brain injuries like cerebral palsy as well as multiple sclerosis</title>
   	 <description>(Medical Xpress) -- In a new study published in Nature Neuroscience, a team of researchers revealed the discovery of a key protein necessary for nerve repair and could lead to the development of a treatment for brain injuries due to a lack of oxygen, such a cerebral palsy, as well as multiple sclerosis, an autoimmune disease that affects adults all over the world.</description>
     <link>http://medicalxpress.com/news/2011-06-infant-brain-injuries-cerebral-palsy.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 27 Jun 2011 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news228366899</guid>
	 
</item>
<item>
     <title>Molecular imaging provides fast and effective diagnosis for patients with fever of unknown origin</title>
   	 <description>Research presented at SNM's 58th Annual Meeting highlights molecular imaging's diagnostic potential for patients with fever of unknown origin. Persistent fever can be a warning sign for a range of diseases that could be dangerous if left untreated. A single, full-body molecular imaging scan may give physicians everything they need to narrow down the cause and determine appropriate treatment.</description>
     <link>http://medicalxpress.com/news/2011-06-molecular-imaging-fast-effective-diagnosis.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 23:40:02 EST</pubDate>
	 <guid isPermaLink="false">news226584833</guid>
	 
</item>


</channel>
</rss>
